These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9303383)

  • 1. Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model.
    Knudsen JD; Fuursted K; Espersen F; Frimodt-Møller N
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1910-5. PubMed ID: 9303383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection.
    Knudsen JD; Fuursted K; Raber S; Espersen F; Frimodt-Moller N
    Antimicrob Agents Chemother; 2000 May; 44(5):1247-54. PubMed ID: 10770759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effect of cefepime with four cephalosporins against pneumococci with various susceptibilities to penicillin, in vitro and in the mouse peritonitis model.
    Knudsen JD; Fuursted K; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 1997 Nov; 40(5):679-86. PubMed ID: 9421316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
    Bajaksouzian S; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1973-6. PubMed ID: 8878565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin.
    Knudsen JD; Frimodt-Møller N; Espersen F
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1253-8. PubMed ID: 7574511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity of teicoplanin and vancomycin against 400 penicillin susceptible and resistant Streptococcus pneumoniae. The French Study Group.
    Goldstein FW; Geslin P; Acar JF
    Eur J Clin Microbiol Infect Dis; 1994 Jan; 13(1):33-4. PubMed ID: 8168558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bactericidal activity of vancomycin and teicoplanin against Streptococcus pneumoniae.
    Felmingham D; Foxall P; O'Hare M; Grüneberg R
    Scand J Infect Dis Suppl; 1990; 72():20-5. PubMed ID: 2151062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.
    Pavie J; Lefort A; Ploy MC; Massias L; Chau F; Garry L; Denis F; Fantin B
    Antimicrob Agents Chemother; 2003 Jun; 47(6):2018-21. PubMed ID: 12760890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci.
    Fasola E; Spangler SK; Ednie LM; Jacobs MR; Bajaksouzian S; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2661-3. PubMed ID: 8913486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility of clinical isolates of Streptococcus pneumoniae.
    Traub WH; Leonhard B
    Chemotherapy; 1996; 42(4):240-7. PubMed ID: 8804790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of penicillin-sensitive and -resistant strains of Streptococcus pneumoniae to new antimicrobial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones.
    Appelbaum PC; Spangler SK; Crotty E; Jacobs MR
    J Antimicrob Chemother; 1989 Apr; 23(4):509-16. PubMed ID: 2545656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampin.
    Klugman KP; Capper T; Bryskier A
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2802-4. PubMed ID: 9124844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein binding and serum bactericidal activities of vancomycin and teicoplanin.
    Dykhuizen RS; Harvey G; Stephenson N; Nathwani D; Gould IM
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1842-7. PubMed ID: 7486929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in-vitro activity of four peptide antibiotics against penicillin-resistant Streptococcus pneumoniae isolated from cerebrospinal fluid (CSF).
    Rodríguez-Tudela JL; López de Felipe F; Martínez-Suárez JV; Fenoll A
    J Antimicrob Chemother; 1992 Mar; 29(3):299-302. PubMed ID: 1317370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of teicoplanin and vancomycin against penicillin-resistant pneumococci.
    Klugman KP
    Eur J Clin Microbiol Infect Dis; 1994 Jan; 13(1):1-2. PubMed ID: 8168552
    [No Abstract]   [Full Text] [Related]  

  • 17. [A comparative microbiological and pharmacokinetic activity of vancomycin and teicoplanin].
    Cohen R; Barre J; Varon E
    Pathol Biol (Paris); 1992 Oct; 40(8):831-44. PubMed ID: 1484744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection.
    Bowker KE; Noel AR; MacGowan AP
    J Antimicrob Chemother; 2009 Nov; 64(5):1044-51. PubMed ID: 19759041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
    Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.
    Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G
    Clin Pharmacokinet; 2008; 47(12):793-805. PubMed ID: 19026035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.